ATON PORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 2.87 $ 0.22 (8.37 %)    

Friday, 21-Nov-2025 12:52:12 EST
QQQ $ 591.06 $ 3.73 (0.64 %)
DIA $ 463.82 $ 4.35 (0.95 %)
SPY $ 660.13 $ 5.11 (0.78 %)
TLT $ 89.30 $ -0.36 (-0.4 %)
GLD $ 376.04 $ 2.05 (0.55 %)
$ 2.68
$ 2.63
$ 2.82 x 3
$ 2.87 x 100
$ 2.62 - $ 2.85
$ 2.65 - $ 15.82
45,209
na
6.11M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON) ("AlphaTON" or the "Company"), a specialized digital asset technology comp...

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON), a leading digital asset company focused on growing the Telegram ecosystem, today announce...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON) – AlphaTON Capital, a leading investm...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON), a specialized digital asset treasury...

Core News & Articles

AlphaTON Capital (NASDAQ:ATON), a leading digital asset infrastructure company focused on Telegram and the TON blockchain ecosy...

Core News & Articles

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyn...

Core News & Articles

Telegram's more than 1 billion monthly active users represent the world's largest untapped market for AI agents that ac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION